Proto Labs 10-Qquarter ended 2026-09-30

PositiveRestructuring

Strategic-account focus and U.S. aerospace & defense demand lift sales from fewer customer contacts; manufacturing costs squeeze gross margin.

Filed 2026-10-29 14:31 ET

Key figures · Q3 FY2026 · period ended 2026-09-30

  • Revenue$154.3MYoY +14.0%QoQ +3.3%
  • Operating income$14.4MYoY +63.9%QoQ +27.1%
  • Net income$11.8MYoY +63.0%QoQ +28.5%
  • Total assets$808.0MQoQ +2.1%
  • Total debtNo debtQoQ −100.0%
  • Shareholders' equity$701.8MYoY +5.6%QoQ +1.5%
  • Tangible book value$412.2MQoQ +2.7%
Notes on other figures in this summary (1)
  • Cash and cash equivalents: Summary: $175M · Filing: $133.8M

    Comment from AI: The summary's $175M combines cash with marketable securities, while this claim's $133.8M is cash and cash equivalents excluding marketable securities.

How this filing reads

  • Health+0.8$175M in cash and securities, no borrowings, and $40.2M nine-month free cash flow support obligations.
  • Momentum+0.7Revenue rose 14% and operating income 64%, while Q3 gross margin fell 80 basis points.
  • Outlook+0.1U.S. aerospace and defense demand strengthened, while Europe’s quarterly operating loss widened to $3.35M.
  • Restructuring“Its 9M results included $2.45M of restructuring and transformation costs and $0.937M of exit/disposal costs.”

Executive Summary

Protolabs earns revenue manufacturing custom parts for businesses through CNC machining, injection molding, 3D printing and sheet-metal services. It is concentrating on larger, strategic customers while investing in automation, digital capabilities and production efficiency. This quarter showed that approach generating more revenue from fewer customer contacts, with U.S. aerospace and defense demand supporting growth. Operating profit grew much faster than sales, but manufacturing costs squeezed quarterly gross margin and Europe continued losing money. The investor question is whether larger customer relationships and technology investment can sustain profitable growth without consuming substantially more cash.

What's Happening in the Business

The shift toward larger accounts is changing Protolabs’ growth model. Q3 customer contacts fell 2.2% to 20,777, while revenue per contact increased 17% to $7,427. Management attributes this primarily to customer mix and its focus on strategic accounts, rather than broader customer participation. U.S. aerospace and defense demand strengthened across CNC machining, injection molding and 3D printing, alongside market-driven price increases.

Management is redeploying restructuring savings into technology, automation, core systems and digital capabilities. Applications of artificial intelligence include pricing and sourcing, inspection, CNC toolpath verification and software development. These investments aim to improve customer experience, production capacity and efficiency; the filing does not yet quantify their returns.

Europe remains the operational weak spot: sales increased, but losses widened. Its 9M results included $2.45M of restructuring and transformation costs and $0.937M of exit/disposal costs. The latter included a $0.9M write-down of an abandoned German facility lease asset—a cost of exiting capacity, not an improvement in manufacturing performance.

Key Financial Highlights

Metric Q3 2026 Y/Y 9M 2026 Y/Y Investor interpretation
Revenue $154M +14% $443M +12% Larger customer relationships and U.S. aerospace and defense demand supported growth.
Gross margin 44.5% −80 bp 45.5% +90 bp Quarterly production-cost pressure interrupted the year-to-date margin improvement.
Operating income $14.4M +64% $35.6M +95% Operating expenses grew much more slowly than revenue.
Net income $11.8M +63% $29.0M +90% A lower tax rate supported earnings; slightly lower other income moderated the year-to-date benefit.
Operating cash flow — — $55.7M −4.0% Receivables absorbed more cash, while accrued liabilities provided less funding.
Free cash flow¹ — — $40.2M −22% Higher capital spending compounded the working-capital drag.

¹ Operating cash flow less capital expenditures.

Geographic segment Q3 revenue Y/Y Q3 operating income/(loss) Y/Y
United States $125M +15% $37.2M +31%
Europe $28.9M +11% $(3.35)M vs $(2.84)M
  • Product drivers: CNC machining revenue reached $73.4M, +16%, and injection molding $53.7M, +12%; together they supplied 86% of the quarterly revenue increase. 3D printing contributed $22.4M, +11%, while sheet metal declined 4.7% to $4.06M.
  • Manufacturing costs: Q3 personnel costs increased $5.4M, raw-material and production costs $4.8M, and equipment and facility costs $1.4M. These increases explain why gross profit did not keep pace with sales.
  • Costs outside segments: Corporate unallocated expenses rose 16% to $19.4M, primarily reflecting R&D, general and administrative expenses and other unallocated costs; these materially reduce consolidated profit relative to U.S. segment profit.
  • Cash and investment: Against 9M net income, OCF benefited from noncash expenses but faced $21.6M of receivables-related cash use versus $11.3M previously. Capital expenditures rose to $15.5M from $6.79M, primarily in the United States.
  • Liquidity and capital returns: Cash plus marketable securities totaled $175M, with no balance-sheet borrowings. Repurchases fell to $10.0M from $36.7M, while shares outstanding increased 1.0% from year-end: buybacks did not offset issuance.

Risk Assessment

  • Larger-account dependence: Revenue growth alongside fewer customer contacts makes continued spending by strategic accounts more consequential; weaker orders could expose the narrowing customer base.
  • European restructuring: Losses widened despite revenue growth, so restructuring and facility exits have not yet demonstrated a sustainable path to profitability.
  • Manufacturing execution: Rising labor, material and facility costs squeezed quarterly gross margin; pricing and automation must offset these pressures to preserve profitability.
  • Currency exposure: Unhedged pound and euro exposure can weaken international results, particularly if the dollar strengthens or the pound strengthens against the euro.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

What to Watch

  • Strategic accounts: Revenue per contact rose while contacts declined; durable growth would show sustained spending without continued erosion of customer participation.
  • Core manufacturing demand: CNC machining and injection molding supplied most incremental sales. Continued growth would validate aerospace and defense strength; slowing orders would challenge that engine.
  • European recovery: Revenue growth has not stopped losses from widening. Narrower losses after restructuring would demonstrate progress; further exits or write-downs would suggest deeper problems.
  • Investment payoff: Capital spending increased sharply as free cash flow fell. Subsequent filings should show whether capacity and automation support margins and cash generation, rather than requiring persistently higher spending.

Longer version: the summary of each of the report's 6 sections, written by an AI model from the same filing.

Changes since the previous 10-Q

Since the Q2 FY2026 10-Q:

  1. Watch item improved European recovery
    Q2 Europe lost $6.6M on $27M revenue; recovery required narrower losses alongside sustained sales. → Q3 loss narrowed to $3.35M on $28.9M revenue, though still wider year over year.
  2. Watch item mixed Production and technology investment
    Q2 gross margin reached 46.4% on 11% sales growth; H1 capital spending was $9.74M. → Q3 gross margin slipped to 44.5% despite 14% sales growth; 9M capital spending reached $15.5M.

Was this summary useful?

Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.

Model 006 · prompt v154 · 2026-10-29 22:48:10Z

Feedback